This inventor holds 2 USPTO granted patents. Top assignees: King Abdulaziz University, University of Jeddah, Helwan University. Active years: 2025.
Company Filing History:
2 out of 588 
2 out of 12 
1 out of 1 Years Active: 2025
Title: Roaa M Alreemi: Innovator in Cancer Treatment
Introduction
Roaa M Alreemi is a prominent inventor based in Jeddah, Saudi Arabia. She has made significant contributions to the field of cancer research, particularly in the development of novel therapeutic agents for the treatment of acute myeloid leukemia and breast cancer. With two patents to her name, her work is paving the way for innovative solutions in oncology.
Latest Patents
Roaa's latest patents include two groundbreaking compounds. The first patent focuses on 2-(5-aminopyridin-2-yl)-N-benzylacetamides, which are identified as potential anticancer therapeutic agents specifically targeting acute myeloid leukemia (AML). Compound I was designed to inhibit growth and induce cell death in AML cells, demonstrating a dose-dependent effect on various AML cell lines, including HL-60, Mv4-11, KG-1a, and K562. The second patent involves Aryl-1,2,3-triazole compounds, which exhibit cytotoxic activities against MCF7 breast cancer cells. These compounds are beneficial in therapeutic regimes for breast cancer, positively affecting key pathways within the cancer cells.
Career Highlights
Roaa M Alreemi has worked at notable institutions such as the University of Jeddah and King Abdulaziz University. Her academic and research endeavors have significantly contributed to the advancement of cancer treatment methodologies.
Collaborations
Throughout her career, Roaa has collaborated with esteemed colleagues, including Hind A Alkhatabi and Mohammed A Baradwan. These partnerships have enhanced her research and expanded the impact of her innovations in the field of oncology.
Conclusion
Roaa M Alreemi is a trailblazer in cancer research, with her innovative patents offering hope for effective treatments against acute myeloid leukemia and breast cancer. Her contributions are vital in the ongoing fight against these diseases.